comparemela.com

Page 9 - Lorraine Nolan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First Irish blood clot case after AstraZeneca vaccine being investigated | JOE is the voice of Irish people at home and abroad

The European Medicines Agency concluded yesterday that CVST, as well splanchnic vein thrombosis - a blood clot in the abdomen - should be listed as very rare side effects of AstraZeneca s vaccine. The Irish Times says the woman is in recovery and is expected to be discharged from the Mater in the next few days. This is after she spent one week in a stroke ward at the hospital. Dr Lorraine Nolan, chief executive of the HPRA, said at Thursday s Department of Health briefing: Today, we received into our database one case report of what we would term a case of special interest and that s because it describes a CVST.

Midwest Radio - NIAC will decide if further guidance is needed on the AstraZeneca vaccine over the coming days

NIAC will decide if further guidance is needed on the AstraZeneca vaccine over the coming days Published: Friday, 09 April 2021 07:15 The Health Products Regulatory Authority says an Irish case of an rare blood clot associated with the Astrazeneca vaccine will be looked at as a priority. The National Immunisation Advisory Committee will decide in the coming days if it needs to issue further guidance to NPHET and the Government over the use of the injection after the EMA said there is a possible link between the clotting event and the vaccine. In the UK, those under 30 will be offered an alternative injection.

We re not there yet : Nphet warns against further easing of Covid restrictions

The woman’s sister, who contacted The Irish Times, said she was “horrendously sick” and that the severity of this is huge. Dr Lorraine Nolan, chief executive of the Health Products Regulatory Authority, which is investigating the case, told Thursday night’s Nphet briefing that the regulator had received “a case of special interest” involving a person with CVST which was receiving the authority’s “utmost priority”. The National Immunisation Advisory Committee met on Thursday to consider the concerns around the AstraZeneca vaccine and was engaging with European colleagues. It is to meet again on Friday morning. Health sources say that vaccinators have reported some resistance among people to the AstraZeneca vaccine in recent days. A delivery of more than 100,000 doses of the vaccine last week means it accounts for a large portion of the shots being administered this week.

HPRA AstraZeneca Update As First Irish Blood Clot Case Investigated

Dr Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA), has given an update on the possible link between AstraZeneca and rare blood clots as the body investigates the first potential event in Ireland. The EMA found that although a connection between the jab and the blood clotting events is plausible, the benefits of the vaccine outweigh the risk of its side effects. Dr Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA), has given an update on the possible link between AstraZeneca and rare blood clots as the body investigates the first potential event in Ireland.  Pic: Sam Boal/RollingNews.ie

Stable, potentially improving situation : The key points you need to know from tonight s NPHET briefing

); A round-up of NPHET’s press briefing at the Department of Health this evening. By Orla Dwyer Thursday 8 Apr 2021, 8:08 PM Thu 8:08 PM 36,982 Views 49 Comments Professor Philip Nolan at the NPHET briefing this evening. Image: Sam Boal Image: Sam Boal PUBLIC HEALTH OFFICIALS this evening confirmed a further 400 cases of Covid-19 and seven additional deaths in Ireland. This evening’s figures mean that there has now been a total of 239,723 cases of Covid-19 in Ireland, along with 4,737 deaths. The deputy Chief Medical Officer Dr Ronan Glynn led tonight’s NPHET briefing, alongside the chair of the NPHET Irish Epidemiological Modelling Advisory Group Professor Philip Nolan, virologist and Director of the National Virus Reference Laboratory Dr Cillian de Gascun and Chief Executive of the Health Products Regulatory

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.